CDMOs are actively exploring and leveraging both new and existing technologies to streamline the cell-line development process at every step.
Eric Rhodes
Advertisement
Eric Rhodes is the CEO of ERS Genomics.
Articles by Eric Rhodes
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on BioPharm International
1
Why Radiopharmaceuticals Are Ideal for Treating Cancer
2
Check Your Knowledge: Patient-Centric Care Through Oral Liquid Delivery
3
Applying Analytical Quality by Design Principles to Biopharma Method Development and Optimization
4
Check Your Knowledge (Answers): Patient-Centric Care Through Oral Liquid Delivery
5
